‘Not just about weight-loss drugs, companies need to do more for children and young people with Type 1 diabetes’
[ad_1] At a time when popular weightloss drugs such as Ozempic/Wegovy and Mounjaro grab headlines and celebrity endorsements, a report from Access to Medicine Foundation
CBSE orders ‘sugar boards’ in schools amid rising childhood diabetes cases
[ad_1] In a proactive health initiative, the CBSE has directed all affiliated schools to establish “sugar boards” aimed at monitoring and curbing excessive sugar consumption
Day 1 after diabetes drug Empagliflozin goes off patent, generics go to town with it
[ad_1] Drugmakers have begun to roll-out their generic versions of diabetes drug Empagliflozin – on day one after the innovative drug from Boehringer Ingelheim (BI)
Glenmark expands diabetes portfolio with new Empagliflozin treatments
[ad_1] Glenmark Pharmaceuticals announced today the launch of Empagliflozin and its fixed-drug combinations in India under the brand names Glempa, Glempa-L, and Glempa-M. The shares
